The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Breast Cancer Screening Test Market During The Forecast Period 2026–2030?
The breast cancer screening test market has exhibited strong growth in recent years. It is projected to increase from $2.49 billion in 2025 to $2.69 billion in 2026, advancing at a compound annual growth rate (CAGR) of 8.3%. The expansion observed in the historic period is credited to heightened awareness of breast cancer incidence, widespread implementation of mammography screening programs, the development of diagnostic laboratory infrastructure, the availability of standardized screening guidelines, and increasing public health screening initiatives.
The breast cancer screening test market is anticipated to experience significant expansion in the upcoming years, projected to reach $3.68 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.1%. This increase over the forecast period is driven by factors such as the rising implementation of personalized cancer screening protocols, enhanced utilization of AI-powered diagnostic tools, broader adoption of genetic testing, a concentrated effort on early-stage cancer detection, and greater investments in preventive oncology services. Prominent trends for the forecast period include the increasing use of advanced imaging-based screening tests, a surge in the application of genetic and molecular diagnostics, the growing integration of AI in image interpretation, the expansion of multi-modal screening approaches, and a stronger emphasis on early and preventive diagnostics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24180&type=smp
What Drivers Are Expected To Influence The Breast Cancer Screening Test Market During The Forecast Period?
An increase in the occurrence of breast cancer is projected to drive expansion within the breast cancer screening test market moving ahead. This condition involves the unchecked multiplication of irregular cells in the breast, capable of forming tumors and potentially metastasizing to other bodily regions. The increase in breast cancer cases is attributable to the world’s aging populace, given that older age represents a significant risk factor for the illness, and extended lifespans result in a greater number of affected individuals. Screening examinations for breast cancer facilitate early detection, thereby improving prospects for effective treatment and decreasing fatalities associated with the disease. For example, as reported by Breastcancer.org, a US-based nonprofit, in March 2025, approximately 316,950 women are anticipated to be diagnosed with invasive breast cancer in 2025, with an additional 59,080 new instances of non-invasive ductal carcinoma in situ (DCIS) expected to be documented. Consequently, the escalating rates of breast cancer incidence are fueling the expansion of the breast cancer screening test market.
What Market Segments Are Evaluated Within The Breast Cancer Screening Test Market?
The breast cancer screening test market covered in this report is segmented –
1) By Diagnostic Test Type: Blood Marker Test, Imaging Test, Genetic Test, Immunohistochemistry Test
2) By Risk Level: High-risk Population, Moderate-risk Population, Average-risk Population
3) By End User: Hospitals, Diagnostic Centres, Cancer Institutes, Research Laboratories
Subsegments:
1) By Blood Marker Test: Circulating Tumor Cells (Ctcs) Test, Gene Expression Profiling Test, Circulating Tumor Dna (Ctdna) Test, Proteomic Biomarker Test
2) By Imaging Test: Mammography, Magnetic Resonance Imaging Screening Test, Molecular Breast Imaging Test, Positron Emission Mammography, Ultrasound
3) By Genetic Test: Fluorescence In Situ Hybridization, Her Gene Test
4) By Immunohistochemistry (Ihc) Test: Estrogen Receptor (Er) Test, Ki-67 Proliferation Marker Test, Progesterone Receptor (Pr) Test, Her2 Or Neu Test
What Industry Trends Are Redefining The Breast Cancer Screening Test Market?
Major companies operating in the breast cancer screening test market are concentrating on developing innovative products, such as mobile cancer screening units, to enhance accessibility, improve early detection rates, and expand screening coverage in underserved and remote areas. A mobile cancer screening unit is a transportable facility equipped with diagnostic imaging technologies, including mammography, designed to provide on-site breast cancer screening services in remote or underserved areas. For instance, in September 2024, Granules India Ltd., an India-based pharmaceutical company, launched a Breast Health Express to boost breast cancer screening in underprivileged communities. This unit features state-of-the-art mammography and ultrasound technology, enabling high-quality screenings on the go, with a focus on reaching underserved and rural communities where access to healthcare facilities may be limited, thus ensuring women in remote areas have access to life-saving early detection services.
Who Are The Top Market Participants Influencing The Breast Cancer Screening Test Market?
Major companies operating in the breast cancer screening test market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Fujifilm Corporation, Koninklijke Philips NV, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Hologic Inc., Hitachi High-Tech Corporation, Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, Provista Diagnostics Inc., Niramai Health Analytix Pvt. Ltd., Kheiron Medical Technologies Limited, UE LifeSciences Inc., BD (Becton Dickinson and Company), Agilent Technologies Inc.
Read the full breast cancer screening test market report here:
https://www.thebusinessresearchcompany.com/report/breast-cancer-screening-test-global-market-report
Which Region Is Forecast To Lead The Breast Cancer Screening Test Market In Terms Of Market Size?
North America was the largest region in the breast cancer screening test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast cancer screening test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Breast Cancer Screening Test Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24180&type=smp
Browse Through More Reports Similar to the Global Breast Cancer Screening Test Market 2026, By The Business Research Company
Cellular Health Screening Market Report 2026
https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report
Next Generation Gynecological Cancer Diagnostics Market Report 2026
Breast Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/breast-cancer-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model